<div class="grid-row grid-col-12 tablet:grid-col-9 main-layout with--content with--sidebar-first without--sidebar-second content-inner-regions" id="main" role="main">
<div class="grid-col-12 block block-layout-builder block-field-blocknodegeneric-lbtitle" id="node-title">
<span class="visually-hidden">Title</span>
<h1 class="block-content">
          
      Opioid Treatment Program (OTP) Compliance Officers
  

      </h1>
</div>
<div class="desktop:grid-col-10 tablet:grid-col-12 block block-layout-builder block-inline-blocklego-text">
<span aria-hidden="true" class="visually-hidden">Body</span>
<div class="block-content">
<div class="clearfix text-formatted field field--name-field-cpnt-body field--type-text-long field--label-hidden field__item"><p>SAMHSA Opioid Treatment Program (OTP) Compliance Officers</p>
<p>SAMHSA’s OTP Compliance Officers process new and renewal certifications for Opioid Treatment Programs (OTPs). In addition, SAMHSA’s OTP Compliance Officers provide OTPs with ongoing guidance and support.</p>
<p>Compliance officers will evaluate periodically the performance of each accreditation body primarily by inspecting selected OTPs and by evaluating the accreditation body’s survey reports. This evaluation determines whether the surveyed and accredited OTPs complied with the Federal opioid treatment standards.</p>
<p>Compliance officers will review requests for exceptions to 42 CFR Part 8. For-cause inspection may be conducted as deemed necessary to ensure OTPs are in compliance and meet treatment standards.</p>
<p>They also work directly with the <a href="https://www.dea.gov/">Drug Enforcement Administration</a> (DEA) and <a href="https://dpt2.samhsa.gov/regulations/smalist.aspx">State Opioid Treatment Authorities</a> (SOTAs) to ensure OTPs meet all federal and state requirements to provide care for individuals with <a href="https://www.samhsa.gov/substance-use/treatment/co-occurring-disorders">opioid use disorders</a> under the <a href="https://www.federalregister.gov/public-inspection/2024-01693/medications-for-the-treatment-of-opioid-use-disorder">Certification of Opioid Treatment Programs, 42 Code of Federal Regulations (CFR) 8</a>.</p>
<p><strong>Contact Us</strong></p>
<p>To speak to the OTP Compliance Officer for your region, please call <a href="tel:240-276-2700">240-276-2700</a> or email <a href="mailto:DPT@samhsa.hhs.gov">DPT@samhsa.hhs.gov</a>.</p>
<p>Individual practitioners interested in assistance regarding treatment of SUDs in their regular practice, should contact CSAT's Buprenorphine Helpdesk at <a href="tel:1-866-287-2728">1-866-BUP-CSAT</a> (1-866-287-2728) or by email at <a href="mailto:providersupport@samhsa.hhs.gov">providersupport@samhsa.hhs.gov</a>.</p>
</div>
</div>
</div>
<div class="grid-col-12 block block-layout-builder block-field-blocknodegeneric-lbfield-last-updated" id="last-updated">
<span aria-hidden="true" class="visually-hidden">Last Updated</span>
<div class="block-content">
<div class="last-updated">
    Last Updated: 11/07/2024
  </div>
</div>
</div>
</div>